|
|
||||||||
a Department of Surgery, Duke University Medical Center, Durham, North Carolina
b Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina
c Department of Medicine, Duke University Medical Center, Durham, North Carolina
Accepted for publication July 23, 2008.
* Address correspondence to Dr Hughes, Duke University Medical Center, Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Box 3051, Durham, NC 27710 (Email: gchad.hughes{at}duke.edu).
Presented at the Fifty-fourth Annual Meeting of the Southern Thoracic Surgical Association, Bonita Springs, FL, Nov 7–10, 2007.
Background: The Gore TAG thoracic endoprosthesis (W. L. Gore and Associates, Flagstaff, AZ) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of thoracic aortic aneurysms on March 23, 2005, and remains the only FDA approved thoracic device to date. We present our experience with the TAG device for the 2 years post-approval to better characterize "real world" use and results outside the clinical trial setting.
Methods: Between March 23, 2005, and March 23, 2007, n = 91 thoracic endograft procedures were performed at our institution. Of these, n = 83 (91%) utilized the TAG device and form the basis of this report. Indications for endovascular repair were: fusiform or saccular aneurysm (n = 43; 52%), acute or chronic dissection (n = 30; 36%), acute or chronic traumatic transection (n = 7; 8%), and false aneurysm after prior aortic surgery (n = 3; 4%). A "hybrid" approach involving carotid-carotid bypass (n = 2), stage I elephant trunk procedure (n = 3), aortic arch debranching (n = 7), or complete visceral debranching (n = 5) was required in 20% of patients to create an adequate landing zone.
Results: Primary technical success rate was 98.8% (n = 82/83). Thirty-day rates of mortality and permanent stroke were both 3.6% (n = 3 each). Permanent paraparesis/paraplegia rate was 2.4% (n = 2). The 30-day rate of vascular or device-related complications requiring additional endovascular or open procedures was 7.2% (n = 6). During a mean duration of follow-up of 14 ± 8 months (range 0–28), there was one late death from aneurysm rupture (1.2%) and one late conversion to open repair (1.2%).
Conclusions: "Real world" utilization of the TAG device includes high rates of off-label use (nearly 50%) and "hybrid" techniques (20%) for the treatment of multiple pathologic entities of the thoracic and thoracoabdominal aorta. Regardless, short to mid-term results appear promising. Longer follow-up is needed to determine the durability of this approach.
This article has been cited by other articles:
![]() |
A. A. Shah, D. M. Craig, N. D. Andersen, J. B. Williams, S. D. Bhattacharya, S. H. Shah, R. L. McCann, and G. C. Hughes Risk factors for 1-year mortality after thoracic endovascular aortic repair J. Thorac. Cardiovasc. Surg., May 1, 2013; 145(5): 1242 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cao, P. De Rango, M. Czerny, A. Evangelista, R. Fattori, C. Nienaber, H. Rousseau, and M. Schepens Systematic review of clinical outcomes in hybrid procedures for aortic arch dissections and other arch diseases J. Thorac. Cardiovasc. Surg., December 1, 2012; 144(6): 1286 - 1300.e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Shah, M. E. Barfield, N. D. Andersen, J. B. Williams, J. A. Shah, J. M. Hanna, R. L. McCann, and G. C. Hughes Results of Thoracic Endovascular Aortic Repair 6 Years After United States Food and Drug Administration Approval Ann. Thorac. Surg., November 1, 2012; 94(5): 1394 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Lee, N. D. Andersen, J. B. Williams, S. D. Bhattacharya, R. L. McCann, and G. C. Hughes Results With a Selective Revascularization Strategy for Left Subclavian Artery Coverage During Thoracic Endovascular Aortic Repair Ann. Thorac. Surg., July 1, 2011; 92(1): 97 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Bhamidipati, D. J. LaPar, G. S. Mehta, J. A. Kern, I. L. Kron, G. R. Upchurch Jr, and G. Ailawadi Have Thoracic Endografting Outcomes Improved Since US Food and Drug Administration Approval? Ann. Thorac. Surg., May 1, 2011; 91(5): 1314 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Parsa, J. B. Williams, S. D. Bhattacharya, W. G. Wolfe, M. A. Daneshmand, R. L. McCann, and G. C. Hughes Midterm results with thoracic endovascular aortic repair for chronic type B aortic dissection with associated aneurysm J. Thorac. Cardiovasc. Surg., February 1, 2011; 141(2): 322 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Fehrenbacher, H. Siderys, C. Terry, J. Kuhn, and J. S. Corvera Early and late results of descending thoracic and thoracoabdominal aortic aneurysm open repair with deep hypothermia and circulatory arrest J. Thorac. Cardiovasc. Surg., December 1, 2010; 140(6_suppl): S154 - S160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Milewski, W. Y. Szeto, A. Pochettino, G. W. Moser, P. Moeller, and J. E. Bavaria Have hybrid procedures replaced open aortic arch reconstruction in high-risk patients? A comparative study of elective open arch debranching with endovascular stent graft placement and conventional elective open total and distal aortic arch reconstruction J. Thorac. Cardiovasc. Surg., September 1, 2010; 140(3): 590 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Hughes, S. M. Lee, M. A. Daneshmand, S. D. Bhattacharya, J. B. Williams, S. W. Tucker Jr, and R. L. McCann Endovascular Repair of Descending Thoracic Aneurysms: Results With "On-Label" Application in the Post Food and Drug Administration Approval Era Ann. Thorac. Surg., July 1, 2010; 90(1): 83 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Parsa, M. A. Daneshmand, B. Lima, K. Balsara, R. L. McCann, and G. C. Hughes Utility of Remote Wireless Pressure Sensing for Endovascular Leak Detection After Endovascular Thoracic Aneurysm Repair Ann. Thorac. Surg., February 1, 2010; 89(2): 446 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kulik, C. F. Castner, and N. T. Kouchoukos Replacement of the descending thoracic aorta: Contemporary outcomes using hypothermic circulatory arrest J. Thorac. Cardiovasc. Surg., February 1, 2010; 139(2): 249 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Parsa, J. N. Schroder, M. A. Daneshmand, R. L. McCann, and G. C. Hughes Midterm Results for Endovascular Repair of Complicated Acute and Chronic Type B Aortic Dissection Ann. Thorac. Surg., January 1, 2010; 89(1): 97 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Preventza, G. H. Wheatley III, J. Williams, V. Ramaiah, J. Rodriguez-Lopez, and E. B. Diethrich Identifying Paraplegia Risk Associated with Thoracic Endografting Asian Cardiovascular and Thoracic Annals, December 1, 2009; 17(6): 568 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Hughes, M. A. Daneshmand, K. R. Balsara, H. A. Achneck, B. Sileshi, S. M. Lee, and R. L. McCann "Hybrid" Repair of Aneurysms of the Transverse Aortic Arch: Midterm Results Ann. Thorac. Surg., December 1, 2009; 88(6): 1882 - 1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Hughes, C. F. Sulzer, R. L. McCann, and M. Swaminathan Endovascular Approaches to Complex Thoracic Aortic Disease Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2008; 12(4): 298 - 319. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |